7-chloro-8-methyl-2-pyridin-3-ylquinoline-4-carboxylic acid, 95.0%, 5g

Tétrakis(triphénylphosphine)palladium(0), min 98%, 1 g, emballage verre

Phenosafranine, 98%, 5g

3-((4-Chlorobenzyl)amino)propanoic acid, 95%, 100mg

2,2,2-Trifluoro-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone, 95.0%, 10g

2-(2-Bromo-5-nitrophenyl)acetic acid, 250mg

Trifluoroacetamidine, 90.0%, 1g

2-Fluoro-3-methoxybenzonitrile, 95.0%, 100g

3-(N-(1,3-Dimethyl-2-oxo-6-(3-propoxyphenoxy)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)sulfamoyl)benzoic acid, 98%, 25mg

N-(4-Aminobutyl)-N-methyl carbamic acid tert-butylester, 95.0%, 25g

4,4'-(Azanediylbis(methylene))dibenzonitrile hydrochloride, 98%, 200mg

4-Hydroxy-5-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid, 97%, 250mg

5-Bromobenzo[b]naphtho[1,2-d]thiophene>97.0%(GC)1g